5300192026-01-012026-03-315300192026-03-315300192026-01-012026-03-31CompositionOfBoardOfDirectors15300192026-03-31CompositionOfBoardOfDirectors15300192026-01-012026-03-31CompositionOfBoardOfDirectors25300192026-03-31CompositionOfBoardOfDirectors25300192026-01-012026-03-31CompositionOfBoardOfDirectors35300192026-03-31CompositionOfBoardOfDirectors35300192026-01-012026-03-31CompositionOfBoardOfDirectors45300192026-03-31CompositionOfBoardOfDirectors45300192026-01-012026-03-31CompositionOfBoardOfDirectors55300192026-03-31CompositionOfBoardOfDirectors55300192026-01-012026-03-31CompositionOfBoardOfDirectors65300192026-03-31CompositionOfBoardOfDirectors65300192026-01-012026-03-31CompositionOfBoardOfDirectors75300192026-03-31CompositionOfBoardOfDirectors75300192026-01-012026-03-31CompositionOfBoardOfDirectors85300192026-03-31CompositionOfBoardOfDirectors85300192026-01-012026-03-31CompositionOfBoardOfDirectors95300192026-03-31CompositionOfBoardOfDirectors95300192026-01-012026-03-31CompositionOfBoardOfDirectors105300192026-03-31CompositionOfBoardOfDirectors105300192026-01-012026-03-31CompositionOfCommittees145300192026-03-31CompositionOfCommittees145300192026-01-012026-03-31CompositionOfCommittees155300192026-03-31CompositionOfCommittees155300192026-01-012026-03-31CompositionOfCommittees165300192026-03-31CompositionOfCommittees165300192026-01-012026-03-31CompositionOfCommittees175300192026-03-31CompositionOfCommittees175300192026-01-012026-03-31CompositionOfCommittees415300192026-03-31CompositionOfCommittees415300192026-01-012026-03-31CompositionOfCommittees425300192026-03-31CompositionOfCommittees425300192026-01-012026-03-31CompositionOfCommittees435300192026-03-31CompositionOfCommittees435300192026-01-012026-03-31CompositionOfCommittees445300192026-03-31CompositionOfCommittees445300192026-01-012026-03-31CompositionOfCommittees685300192026-03-31CompositionOfCommittees685300192026-01-012026-03-31CompositionOfCommittees695300192026-03-31CompositionOfCommittees695300192026-01-012026-03-31CompositionOfCommittees705300192026-03-31CompositionOfCommittees705300192026-01-012026-03-31CompositionOfCommittees715300192026-03-31CompositionOfCommittees715300192026-01-012026-03-31CompositionOfCommittees955300192026-03-31CompositionOfCommittees955300192026-01-012026-03-31CompositionOfCommittees965300192026-03-31CompositionOfCommittees965300192026-01-012026-03-31CompositionOfCommittees975300192026-03-31CompositionOfCommittees975300192026-01-012026-03-31CompositionOfCommittees985300192026-03-31CompositionOfCommittees985300192026-01-012026-03-31CompositionOfCommittees995300192026-03-31CompositionOfCommittees995300192026-01-012026-03-31CompositionOfCommittees1005300192026-03-31CompositionOfCommittees1005300192026-01-012026-03-31CompositionOfCommittees1015300192026-03-31CompositionOfCommittees1015300192026-01-012026-03-31CompositionOfCommittees1025300192026-03-31CompositionOfCommittees1025300192026-01-012026-03-31CompositionOfCommittees1225300192026-03-31CompositionOfCommittees1225300192026-01-012026-03-31CompositionOfCommittees1235300192026-03-31CompositionOfCommittees1235300192026-01-012026-03-31CompositionOfCommittees1245300192026-03-31CompositionOfCommittees1245300192026-01-012026-03-31CompositionOfCommittees1255300192026-03-31CompositionOfCommittees1255300192026-01-012026-03-31CompositionOfCommittees1265300192026-03-31CompositionOfCommittees1265300192026-01-012026-03-31CompositionOfCommittees1275300192026-03-31CompositionOfCommittees1275300192026-01-012026-03-31CompositionOfCommittees1285300192026-03-31CompositionOfCommittees1285300192026-03-31MeetingOfBoardOfDirectors15300192026-01-012026-03-31MeetingOfBoardOfDirectors15300192026-03-31MeetingOfBoardOfDirectors25300192026-01-012026-03-31MeetingOfBoardOfDirectors25300192026-01-012026-03-31MeetingOfCommittees15300192026-03-31MeetingOfCommittees15300192026-01-012026-03-31MeetingOfCommittees25300192026-03-31MeetingOfCommittees25300192026-01-012026-03-31MeetingOfCommittees35300192026-03-31MeetingOfCommittees35300192026-01-012026-03-31MeetingOfCommittees45300192026-03-31MeetingOfCommittees45300192026-01-012026-03-31MeetingOfCommittees55300192026-03-31MeetingOfCommittees55300192025-12-315300192026-03-31UnlistedCompanyDomain15300192026-01-012026-03-31UnlistedCompanyDomain15300192025-12-31UnlistedCompanyDomain15300192026-03-31OngoingTaxLitigationsOrDisputesDomain15300192026-03-31OngoingTaxLitigationsOrDisputesDomain25300192026-03-31OngoingTaxLitigationsOrDisputesDomain35300192026-03-31OngoingTaxLitigationsOrDisputesDomain45300192026-03-31OngoingTaxLitigationsOrDisputesDomain55300192026-03-31OngoingTaxLitigationsOrDisputesDomain6xbrli:pure530019JUBLPHARMANOTLISTEDINE700A01033JUBILANT PHARMOVA LIMITED2025-04-012026-03-31Yearly2026-03-31EquitytruetruetruefalseThere was no fine and penalty for the quarter ended March 31, 2026, requiring disclosure under this report. truefalseThere was no loans / guarantees / comfort letters / securities etc. for the quarter ended March 31, 2026, requiring disclosure under this report.trueTop 500 listed entitiestrueJ00122Original1. Mr. Arjun S. Bhartia is Joint MD of the Company. Since there is no option available for Joint MD in Column L, category 3 of directors, therefore we have selected Managing Director as the designation of Mr. Arjun S. Bhartia. 2. As per Circular Ref. No. NSE/CML/2023/31 dated April 10, 2023 issued by the NSE, the Company has considered the No. of post of Chairperson in Audit/Stakeholder Committee held includes public limited companies whether listed or not.truetrueMrShyam Sunder Bhartia******00010484Non-Executive - Non Independent DirectorChairperson related to Promoter1952-11-09falseActiveNA1978-06-211999-01-284000MrHari Shanker Bhartia******00010499Non-Executive - Non Independent DirectorNot Applicable1956-12-12falseActiveNA1983-11-012022-04-016320MrSushil Kumar Roongta******00309302Non-Executive - Independent DirectorNot Applicable1950-05-09falseActiveYes2021-09-222017-05-232022-05-231066671MrVivek Mehra******00101328Non-Executive - Independent DirectorNot Applicable1955-04-21falseActiveNA2017-05-232022-05-231066694MrArun Seth******00204434Non-Executive - Independent DirectorNot Applicable1951-11-19falseActiveYes2023-08-312018-10-222023-10-228944105MrShirish Gundopant Belapure******02219458Non-Executive - Independent DirectorNot Applicable1953-07-19falseActiveNA2023-03-072023-03-07374431MrPriyavrat Bhartia******00020603Executive DirectorNot ApplicableMD1976-10-04falseActiveNA2017-05-232023-06-016040MrArjun Shanker Bhartia******03019690Executive DirectorNot ApplicableMD1987-02-21falseActiveNA2017-05-232023-06-013000MsShivpriya Nanda******01313356Non-Executive - Independent DirectorNot Applicable1963-05-04falseActiveNA2024-04-012024-04-01242241MrHarsh Mahajan******00824227Non-Executive - Independent DirectorNot Applicable1959-03-31falseActiveNA2024-04-012024-04-01241110truetruetruetruetrueAudit Committee00101328Vivek MehraNon-Executive - Independent DirectorChairperson2018-01-17Audit Committee00309302Sushil Kumar RoongtaNon-Executive - Independent DirectorMember2024-02-02Audit Committee00204434Arun SethNon-Executive - Independent DirectorMember2024-05-21Audit Committee01313356Shivpriya NandaNon-Executive - Independent DirectorMember2024-05-21Nomination and remuneration committee00309302Sushil Kumar RoongtaNon-Executive - Independent DirectorChairperson2018-01-17Nomination and remuneration committee00010484Shyam Sunder BhartiaNon-Executive - Non Independent DirectorMember2014-05-26Nomination and remuneration committee00101328Vivek MehraNon-Executive - Independent DirectorMember2018-01-17Nomination and remuneration committee00204434Arun SethNon-Executive - Independent DirectorMember2024-05-21Stakeholders Relationship Committee00204434Arun SethNon-Executive - Independent DirectorChairperson2019-02-01Stakeholders Relationship Committee00020603Priyavrat BhartiaExecutive DirectorMember2024-02-02Stakeholders Relationship Committee00824227Harsh MahajanNon-Executive - Independent DirectorMember2024-05-21Stakeholders Relationship Committee01313356Shivpriya NandaNon-Executive - Independent DirectorMember2024-05-21Risk Management Committee00309302Sushil Kumar RoongtaNon-Executive - Independent DirectorChairperson2019-02-01Risk Management Committee00204434Arun SethNon-Executive - Independent DirectorMember2019-02-01Risk Management Committee02219458Shirish Gundopant BelapureNon-Executive - Independent DirectorMember2023-03-07Risk Management Committee00020603Priyavrat BhartiaExecutive DirectorMember2023-05-29Risk Management Committee03019690Arjun Shanker BhartiaExecutive DirectorMember2023-05-29Risk Management Committee00101328Vivek MehraNon-Executive - Independent DirectorMember2024-05-21Risk Management Committee01313356Shivpriya NandaNon-Executive - Independent DirectorMember2024-05-21Risk Management Committee00824227Harsh MahajanNon-Executive - Independent DirectorMember2024-05-21Corporate Social Responsibility Committee01313356Shivpriya NandaNon-Executive - Independent DirectorChairperson2024-05-21Corporate Social Responsibility Committee00309302Sushil Kumar RoongtaNon-Executive - Independent DirectorMember2018-01-17Corporate Social Responsibility Committee00020603Priyavrat BhartiaExecutive DirectorMember2018-01-17Corporate Social Responsibility Committee03019690Arjun Shanker BhartiaExecutive DirectorMember2018-01-17Corporate Social Responsibility Committee02219458Shirish Gundopant BelapureNon-Executive - Independent DirectorMember2024-02-02Corporate Social Responsibility Committee00204434Arun SethNon-Executive - Independent DirectorMember2024-05-21Corporate Social Responsibility Committee00824227Harsh MahajanNon-Executive - Independent DirectorMember2024-05-212025-10-31true101062026-02-0697true10106Audit Committee2025-10-31true4440Audit Committee2026-02-0596true4440Nomination and remuneration committee2025-10-31true4430Risk Management Committee2025-12-03true8760Corporate Social Responsibility Committee2025-12-03true7650truetruetruetrueYestruetruetrueNaresh KapoorCompany Secretary and Compliance OfficerYeshttps://www.jubilantpharmova.com/about-us/company-profileYeshttps://www.jubilantpharmova.com/investors/disclosure-under-regulation-46-and-62-of-the-LODRYeshttps://www.jubilantpharmova.com/about-us/management/board-of-directorsYeshttps://www.jubilantpharmova.com/Uploads/image/2035imguf_TermsandconditionsofappointmentofIndependentDirectors.pdfYeshttps://www.jubilantpharmova.com/Uploads/image/2238imguf_list-commiteewise.pdfYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/code-of-conductYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/whistle-blower-policyYeshttps://www.jubilantpharmova.com/investors/disclosure-under-regulation-46-and-62-of-the-LODRYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/policy-on-rptsYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/policy-for-determining-material-subsidiariesYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/familiarisation-programme-for-independent-directorsYeshttps://www.jubilantpharmova.com/investors/investor-contact/investor-grievancesYeshttps://www.jubilantpharmova.com/investors/investor-contact/investor-grievancesYeshttps://www.jubilantpharmova.com/investors/financials/quarterly-resultsYeshttps://www.jubilantpharmova.com/investors/investor-information/share-holding-patternNAYeshttps://www.jubilantpharmova.com/investors/jubilant-pharmova-investors-meet-2025Yeshttps://www.jubilantpharmova.com/investors/jubilant-pharmova-investors-meetsYeshttps://www.jubilantpharmova.com/investors/investor-information/change-of-nameYeshttps://www.jubilantpharmova.com/investors/disclosure/notices-given-to-shareholders-by-advertisementYeshttps://www.jubilantpharmova.com/investors/investor-information/credit-ratingsYeshttps://www.jubilantpharmova.com/investors/financials/subsidiaries-accountsYeshttps://www.jubilantpharmova.com/investors/disclosure/annual-secretarial-complaince-reportYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/policy-for-determination-of-materiality-of-events-and-informationYeshttps://www.jubilantpharmova.com/investors/investor-contact/kmp-reg30Yeshttps://www.jubilantpharmova.com/investors/disclosure/disclsoures-under-30_8NAYeshttps://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/dividend-distribution-policyYeshttps://www.jubilantpharmova.com/investors/financials/annual-returnYeshttps://www.jubilantpharmova.com/Uploads/image/2491imguf_jpm-employee-stock-option-plan-2018.pdfYeshttps://www.jubilantpharmova.com/investors/disclosure-under-regulation-46-and-62-of-the-LODRYeshttps://www.jubilantpharmova.com/investors/disclosure-under-regulation-46-and-62-of-the-LODRYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesYesYesNAYesYesYesYesYesYesNAYesYesYesNAYesNARESH KAPOORCompany Secretary and Compliance OfficerYesNaresh KapoorCompany Secretary and Compliance OfficerfalseNaresh KapoorCompany Secretary and Compliance OfficerNoida2026-04-2903300Acquisition of 92,56,291 Equity Shares of Forum 1 Aviation Private Limited through Rights Issue.Forum I Aviation Private Limited2026-01-290.175500.1755Income Tax Department2017-03-28Appeal filed by Jubilant Pharmova Limited and pending before CIT (Appeals) w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs. 58.15 crs for various years Date of Initiation of Litigation " 28/02/2022 (FY 09 and FY 10); 13/05/2022 (FY 11); 20/09/2017 (FY 12); 28/03/2017 (FY 13); 17/04/2018 (FY 14); 22/02/2019 (FY 15)No change. Jubilant Pharmova Limited expects to get relief from the Appellate Authority and does not anticipate any material adverse financial implicationJubilant Pharmova Limited2017-09-20Appeal filed by Income Tax Department against Jubilant Pharmova Limited and pending before Income Tax Appellate Tribunal (ITAT) w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs. 9.47 crsNo change. Jubilant Pharmova Limited expects Hon'ble ITAT, Delhi to sustain the order of CIT- Appeals and does not anticipate any material adverse financial implicationIncome Tax Department2024-04-24Appeal filed before CIT(Appeals) against order passed u/s 153C for various years, the tax effect of which is Rs. 4.43 crs.No change. Order for AY 15-16 has been quashed by CIT(A). For AY 16-17, 17-18 and 18-19. Revised Tax effect is Rs.4.32 crs.Jubilant Biosys Limited, a wholly owned Indian subsidiary of Jubilant Pharmova Limited2019-04-24Appeal filed by Income Tax Department against Jubilant Biosys Limited and pending before Allahabad High Court w.r.t. denial of deduction with respect to payment to related party by invoking the provision of section 80IB (13) r.w. section 80IA (10) of the Act and disallowance of entire expenditure debited in P & L account by treating the same as Capital expenditure - Rs.228.87 crsNo change. Jubilant Biosys Limited expects Hon'ble Allahabad High Court to sustain the order of the Hon'ble ITAT, Delhi and does not anticipate any material adverse financial implicationIncome Tax Department2024-09-20Appeal filed by Jubilant Generics Limited (wholly owned subsidiary of Jubilant Pharmova Limited) and pending before Income Tax Appellate Tribunal (ITAT) w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises. For FY 18 matter has been remanded back by ITAT to file of the AO for evaluation . Date of Initiation of Litigation 25-08-2022 (FY 18); 20-09-2024 (FY 20). Tax impact of the adjustments on carried forward losses is Rs 36.03 crores basis the prevalent tax rates.Case for AY 20-21 has been quashed by ITAT subject to certain caveats.Income Tax Department2025-12-27Tax demand of Rs. 22.10 crs vide orders passed in AY 20-21 . Demand primarily arising on account of arithmetical errors and mistakes apparent from records apart from certain disallowances of deductions and transfer pricing adjustments ignoring the contentions of the company. Company expects the deletion of Tax Demand of Rs. 22.10 crs in due course. Appeal filing process before ITAT is under process.No change. Jubilant Pharmova Limited expects to get relief from the Appellate Authority and does not anticipate any material adverse financial implication